Srinivas N. Pentyala
Director/Board Member at Translational Research Group, Inc.
Profile
Srinivas N.
Pentyala is a Director of Affinimark Technologies, Inc. He is a Faculty Member of Anesthesiology, Urology, Health sciences, Physiology, and Biophysics at the Medical School of the State University of New York.
Dr. Pentyala is a Director for Translational Research.
He is a Course Director for the New York State Center for Biotechnology.
Dr. Pentyala worked as a Professor and Faculty Member at Stony Brook University.
He holds a PhD.
Srinivas N. Pentyala active positions
| Companies | Position | Start |
|---|---|---|
| The State University of New York | Corporate Officer/Principal | - |
| Translational Research Group, Inc. | Director/Board Member | - |
Former positions of Srinivas N. Pentyala
| Companies | Position | End |
|---|---|---|
| Stony Brook University | Corporate Officer/Principal | - |
Affinimark Technologies, Inc.
 Affinimark Technologies, Inc. Medical SpecialtiesHealth Technology Affinimark Technologies, Inc. develops proprietary medical diagnostic products. Its products address lucrative market opportunities and serious unmet medical/surgical needs and its lead product, cerebrostripTM, is a strip-based diagnostic test, derived from affinimark's own cutting edge research that will quickly and cost-effectively provide a definitive determination whether the patient has suffered a cerebrospinal fluid leak as a result of surgery or trauma. The company was founded by Harry H. Penner, Jr. and Levesque Christopher in 2007 and is headquartered in New Haven, CT. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Affinimark Technologies, Inc.
Affinimark Technologies, Inc. Medical SpecialtiesHealth Technology Affinimark Technologies, Inc. develops proprietary medical diagnostic products. Its products address lucrative market opportunities and serious unmet medical/surgical needs and its lead product, cerebrostripTM, is a strip-based diagnostic test, derived from affinimark's own cutting edge research that will quickly and cost-effectively provide a definitive determination whether the patient has suffered a cerebrospinal fluid leak as a result of surgery or trauma. The company was founded by Harry H. Penner, Jr. and Levesque Christopher in 2007 and is headquartered in New Haven, CT. | Health Technology |
| Translational Research Group, Inc. |
- Stock Market
- Insiders
- Srinivas N. Pentyala
